3 Ways CTMS Helps Manage Adaptive Trials - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
3 Ways CTMS Helps Manage Adaptive Trials

Source: Applied Clinical Trials

This was originally posted on the Bio-Optronics blog.

While adaptive trial designs have been slow to gain traction, there a many benefits to adopting this trial model. While fear from additional FDA scrutiny is a major concern for many research organizations, it is not the sole reason why the industry has not seen a more widespread adoption of adaptive trial designs. These reasons include having difficulty managing the more complex trial designs and difficulty communicating changes across all of the organizations participating in a particular trial. While not all problems can be addressed by a clinical trial management system (CTMS), utilizing a CTMS in the management of adaptive trial designs can greatly benefit a research organization.

Manage Complex Protocol Designs

An all too common issue researchers’ face with adaptive trial designs is how to manage the complex protocol designs. Paper and MS Excel methods for managing complex and changing protocols can be nearly impossible. The right CTMS can provide the necessary solution for research organizations in this scenario. The right CTMS can help sites, CROs, AROs, other research networks, and sponsors simplify their workflow and the complex environment around them. The investigative staff should be able to easily add procedures to the protocols, and change them as needed. A product should provide flexibility that can handle many amendments and will allow the user to determine when each is activated and can apply the changes going forward. 

Cost and Time Reductions

Using CTMS to manage adaptive trial designs can also provide significant reductions in time by streamlining processes and eliminating unnecessary administrative tasks. In conjunction with the reduction in time, a significant cost savings can be achieved for research organizations.

Communication

In any clinical trial communication between partners is critical to the success of a trial. This is especially try in situations where the protocols of a trial can change in a moment’s notice. CTMS systems can play a major role in improving communication between research organizations. As protocols change everybody can be automatically notified to ensure that everybody is operating off of the same sat of protocols, ensuring trial accuracy.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
87%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
8%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here